DFTX · Categories · Form 4
DFTX - SEC Form 4 insider transactions
Definium Therapeutics Inc. (DFTX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for DFTX
- SEC Form 4 filed by Karlin Daniel4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
- SEC Form 4 filed by Sullivan Mark4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
- SEC Form 4 filed by Barrow Robert4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
- Chief Commercial Officer Wiley Matthew T. was granted 115,000 shares (SEC Form 4)4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
- Chief Financial Officer Roberts Brandi was granted 150,000 shares (SEC Form 4)4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
- Chief Legal Officer Sullivan Mark was granted 125,000 shares, increasing direct ownership by 44% to 407,576 units (SEC Form 4)4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
- Chief Medical Officer Karlin Daniel was granted 150,000 shares, increasing direct ownership by 35% to 575,025 units (SEC Form 4)4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
- Chief Executive Officer Barrow Robert was granted 320,000 shares, increasing direct ownership by 41% to 1,098,477 units (SEC Form 4)4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
- SEC Form 4 filed by Director Adsett Roger4 - Definium Therapeutics, Inc. (0001813814) (Issuer)